Treatment coming for disease that scars the lungs
Plans are under way to upgrade the JGH’s ability to treat individuals with interstitial lung disease, an ailment—often of unknown origin—that causes progressive scarring of the lung tissue, thereby sharply reducing the amount of oxygen that enters the bloodstream.